Skip to main content

Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

Publication ,  Journal Article
Streiff, MB; Holmstrom, B; Angelini, D; Ashrani, A; Elshoury, A; Fanikos, J; Fertrin, KY; Fogerty, AE; Gao, S; Goldhaber, SZ; Gundabolu, K ...
Published in: J Natl Compr Canc Netw
October 15, 2021

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cancer-Associated Venous Thromboembolic Disease focus on the prevention, diagnosis, and treatment of patients with cancer who have developed or who are at risk for developing venous thromboembolism (VTE). VTE is a significant concern among cancer patients, who are at heightened risks for developing as well as dying from the disease. The management of patients with cancer with VTE often requires multidisciplinary efforts at treating institutions. The NCCN panel comprises specialists from various fields: cardiology, hematology/hematologic oncology, internal medicine, interventional radiology, medical oncology, pharmacology/pharmacy, and surgery/surgical oncology. This article focuses on VTE prophylaxis for medical and surgical oncology inpatients and outpatients, and discusses risk factors for VTE development, risk assessment tools, as well as management methods, including pharmacological and mechanical prophylactics. Contraindications to therapeutic interventions and special dosing, when required, are also discussed.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

October 15, 2021

Volume

19

Issue

10

Start / End Page

1181 / 1201

Location

United States

Related Subject Headings

  • Venous Thrombosis
  • Venous Thromboembolism
  • Risk Factors
  • Oncology & Carcinogenesis
  • Neoplasms
  • Medical Oncology
  • Humans
  • Anticoagulants
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Streiff, M. B., Holmstrom, B., Angelini, D., Ashrani, A., Elshoury, A., Fanikos, J., … Nguyen, M. Q. (2021). Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 19(10), 1181–1201. https://doi.org/10.6004/jnccn.2021.0047
Streiff, Michael B., Bjorn Holmstrom, Dana Angelini, Aneel Ashrani, Amro Elshoury, John Fanikos, Kleber Yotsumoto Fertrin, et al. “Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw 19, no. 10 (October 15, 2021): 1181–1201. https://doi.org/10.6004/jnccn.2021.0047.
Streiff MB, Holmstrom B, Angelini D, Ashrani A, Elshoury A, Fanikos J, et al. Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021 Oct 15;19(10):1181–201.
Streiff, Michael B., et al. “Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw, vol. 19, no. 10, Oct. 2021, pp. 1181–201. Pubmed, doi:10.6004/jnccn.2021.0047.
Streiff MB, Holmstrom B, Angelini D, Ashrani A, Elshoury A, Fanikos J, Fertrin KY, Fogerty AE, Gao S, Goldhaber SZ, Gundabolu K, Ibrahim I, Kraut E, Leavitt AD, Lee A, Lee JT, Lim M, Mann J, Martin K, McMahon B, Moriarty J, Morton C, Ortel TL, Paschal R, Schaefer J, Shattil S, Siddiqi T, Sudheendra D, Williams E, Hollinger L, Nguyen MQ. Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021 Oct 15;19(10):1181–1201.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

October 15, 2021

Volume

19

Issue

10

Start / End Page

1181 / 1201

Location

United States

Related Subject Headings

  • Venous Thrombosis
  • Venous Thromboembolism
  • Risk Factors
  • Oncology & Carcinogenesis
  • Neoplasms
  • Medical Oncology
  • Humans
  • Anticoagulants
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis